Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vyndaqel
Pharma
BridgeBio's Attruby off to strong start as it challenges Pfizer
BridgeBio reported that 1,028 prescriptions have been written for Attruby, which was launched on Dec. 11. Evercore touted the launch's "great start."
Kevin Dunleavy
Feb 20, 2025 11:23am
Market growth will help spark sales of Amvuttra, Alnylam says
Feb 13, 2025 2:08pm
JPM25: BridgeBio's cardiomyopathy drug is off to a roaring start
Jan 13, 2025 9:40pm
Look out, Pfizer: BridgeBio gains 'best-case' FDA nod for Attruby
Nov 25, 2024 7:59am
Pfizer's ATTR drug again faces pricing scrutiny
Oct 21, 2024 2:55pm
Alnylam sees Amvuttra as potential standard of care in ATTR-CM
Aug 30, 2024 10:06am
